Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms

被引:0
作者
Bruno L. Oliveira
Irina S. Moreira
Pedro A. Fernandes
Maria J. Ramos
Isabel Santos
João D. G. Correia
机构
[1] Universidade Técnica de Lisboa,Unidade de Ciências Químicas e Radiofarmacêuticas, IST/ITN, Instituto Superior Técnico
[2] Universidade do Porto,REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências
来源
Journal of Molecular Modeling | 2013年 / 19卷
关键词
Docking; Isoselectivity; Medicinal chemistry; Molecular dynamics; Nitric oxide synthase;
D O I
暂无
中图分类号
学科分类号
摘要
Selective inhibition of the nitric oxide synthase isoforms (NOS) is a promising approach for the treatment of various disorders. However, given the high active site conservation among all NOS isoforms, the design of selective inhibitors is a challenging task. Analysis of the X-ray crystal structures of the NOS isoforms complexed with known inhibitors most often gives no clues about the structural determinants behind the selective inhibition since the inhibitors share the same binding conformation. Aimed at a better understanding of the structural factors responsible for selective inhibition of NOS isoforms we have performed MD simulations for iNOS, nNOS and eNOS complexed with Nω-NO2-L-Arg (1), and with the aminopyridine derivatives 2 and 3. The slightly better selectivity of 1 for nNOS may be assigned to the presence of extra charge–charge interactions due to its “extended” conformation. While the high affinity of 2 for iNOS can be explained by the formation of an iNOS-specific subpocket upon binding, the lack of affinity for eNOS is associated to a conformational change in Glu363. The strong van der Waals and electrostatic interactions between 3 and the active site of nNOS are most likely responsible for its higher affinity for this isoform. Owing to the elongated and narrow binding pocket of iNOS, the correct positioning of 3 over the heme group is difficult, which may account for its lower affinity toward this isoform. Brought together, our results might help to rationalize the design of selective NOS inhibitors.
引用
收藏
页码:1537 / 1551
页数:14
相关论文
共 335 条
[1]  
Alderton WK(2001)Nitric oxide synthases: structure, function and inhibition Biochem J 357 593-615
[2]  
Cooper CE(1991)Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 109-142
[3]  
Knowles RG(2005)Structure-function studies on nitric oxide synthases J Inorg Biochem 99 293-305
[4]  
Moncada S(2011)The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis Nat Rev Drug Discov 10 277-291
[5]  
Palmer RM(2009)Selective neuronal nitric oxide synthase inhibitors Front Med Chem 4 842-882
[6]  
Higgs EA(2003)Nitric oxide and cancer: an introduction Free Radic Biol Med 34 951-954
[7]  
Li H(1995)Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 239-242
[8]  
Poulos TL(2002)Blocking NO synthesis: how, where and why? Nat Rev Drug Discov 1 939-950
[9]  
Leiper J(2003)Novel inhibitors of neuronal nitric oxide synthase Exp Biol Med 228 486-490
[10]  
Nandi M(2003)Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats Clin Sci 105 483-489